Monthly News Roundup: October 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and retweets decide which stories make it beyond your newsfeed and onto our blog.

This month, we bring you: a look at the future of patient engagement, a discussion of best practices for vendor evaluation, and and a new market report. Take a look, and tune in for the next roundup in a month!

1. Looking at patient engagement through technology

From the human genome project to precision medicine, innovations to tailor treatments to individual patients have long fascinated the healthcare and clinical research industries. Last month, we shared an article that discussed how artificial intelligence and other modern technology will take these efforts even further, bringing better information and more options to patients everywhere. The article predicts major steps in this direction by 2030. It’s yet another sign that we’re headed toward a future characterized by patient engagement and improved public health.

2. Guidance for sponsors evaluating CROs

Clinical research is full of high-stakes decisions. Just as important as what EDC solution to utilize, for example, is the decision, for sponsors, of what CRO to contract for their clinical trials. And in an age of increased outsourcing from sponsors to CROs, this particular question has taken on even greater significance. In an article we recently shared, a biotech expert offers insight into best practices, and important items to consider, when evaluating CROs. According to the expert, these include the importance of elements such as close communication, transparency, and multidimensional service.

3. The state of the global clinical trial service market

A quick internet search will prove that there’s no shortage of growth forecasts for a multitude of industries related to clinical research, from EDC to CROs and beyond. We recently shared an announcement of a report analyzing the current state of the global clinical trial service market and its potential for future growth through 2022. The article summarizes the key findings of the report, which include insight into the increased complexity of clinical trials, the need for more cost-efficient drug development, the place in the industry for niche CROs, and more.

That’s all for this roundup! We’ll have three more stories for you next month. In the meantime, check out this blog every week for new insights into EDC and clinical research.

| |

Recent Posts